These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6450527)

  • 1. Intracoronary thrombolysis in evolving myocardial infarction.
    Ganz W; Buchbinder N; Marcus H; Mondkar A; Maddahi J; Charuzi Y; O'Connor L; Shell W; Fishbein MC; Kass R; Miyamoto A; Swan HJ
    Am Heart J; 1981 Jan; 101(1):4-13. PubMed ID: 6450527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary thrombolysis in acute myocardial infarction: experimental background and clinical experience.
    Ganz W; Ninomiya K; Hashida J; Fishbein MC; Buchbinder N; Marcus H; Mondkar A; Maddahi J; Shah PK; Berman D; Charuzi Y; Geft I; Shell W; Swan HJ
    Am Heart J; 1981 Dec; 102(6 Pt 2):1145-9. PubMed ID: 7315719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary thrombolysis in acute myocardial infarction.
    Ganz W
    Am J Cardiol; 1983 Jul; 52(2):92A-95A. PubMed ID: 6223519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for and limitations of coronary thrombolysis.
    Kanmatsuse K; Kajiwara N; Onikura S; Satoh Y; Andoh T
    Jpn Circ J; 1985 Jun; 49(6):597-604. PubMed ID: 3162042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.
    Cowley MJ; Hastillo A; Vetrovec GW; Fisher LM; Garrett R; Hess ML
    Circulation; 1983 May; 67(5):1031-8. PubMed ID: 6831667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracoronary streptokinase in acute myocardial infarction.
    Cowley MJ; Hastillo A; Vetrovec GW; Hess ML
    Am Heart J; 1981 Dec; 102(6 Pt 2):1149-58. PubMed ID: 7315720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of percutaneous transluminal coronary recanalization utilizing streptokinase thrombolysis in patients with acute myocardial infarction.
    Lee G; Amsterdam EA; Low R; Joye JA; Kimchi A; DeMaria AN; Mason DT
    Am Heart J; 1981 Dec; 102(6 Pt 2):1159-67. PubMed ID: 6459019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracoronary thrombolysis in acute myocardial infarction].
    Kanmatsuse K; Kajiwara N
    J Cardiogr Suppl; 1984; (3):69-80. PubMed ID: 6536693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ
    Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the fibrinolytic system during intracoronary streptokinase administration.
    Six AJ; Brommer EJ; Müller EJ; Kerkhoff HF
    J Am Coll Cardiol; 1987 Jan; 9(1):189-96. PubMed ID: 3794096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary thrombolysis for evolving myocardial infarction.
    Spann JF; Sherry S
    Drugs; 1984 Nov; 28(5):465-83. PubMed ID: 6391890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase.
    Rentrop KP; Blanke H; Karsch KR; Wiegand V; Köstering H; Oster H; Leitz K
    Clin Cardiol; 1979 Oct; 2(5):354-63. PubMed ID: 121799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
    Johnson ES; Cregeen RJ
    Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
    Van de Werf F; Nobuhara M; Collen D
    Ann Intern Med; 1986 Mar; 104(3):345-8. PubMed ID: 3080936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.
    Francis CW; Connaghan DG; Marder VJ
    Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic markers of fibrinolysis after unsuccessful intracoronary streptokinase thrombolysis for acute myocardial infarction. Does nonreperfusion indicate failure to achieve a systemic lytic state?
    White CW; Schwartz JL; Ferguson DW; Brayden GP; Kelly KJ; Kioschos JM; Marcus ML
    Am J Cardiol; 1984 Oct; 54(7):712-7. PubMed ID: 6486019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.
    MacLennan BA; McMaster A; Webb SW; Khan MM; Adgey AA
    Br Heart J; 1986 Mar; 55(3):231-9. PubMed ID: 3954907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ
    Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.
    Rogers WJ; Mantle JA; Hood WP; Baxley WA; Whitlow PL; Reeves RC; Soto B
    Circulation; 1983 Nov; 68(5):1051-61. PubMed ID: 6352081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.